✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Haleos Labs Ltd.

SMSLIFE

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹339 Cr.
P/E
19.64

Haleos Labs Ltd.

  • Haleos Labs
  • Nectar Lifesciences
  • Everest Organics
  • TJI Pharma - Small Cap

FAQs on Haleos Labs Ltd. Shareprice

Haleos Labs has given better returns compared to its competitors.
Haleos Labs has grown at ~11.47% over the last 8yrs while peers have grown at a median rate of -1.93%

Yes, Haleos Labs is expensive.
Latest PE of Haleos Labs is 19.35, while 3 year average PE is 18.12.
Also latest EV/EBITDA of Haleos Labs is 10.3 while 3yr average is 9.85.

View FAQ's On Business

Growth Table

  • Haleos Labs Ltd.
  • Nectar Lifesciences
  • Everest Organics

Balance Sheet

  • Haleos Labs Ltd.
  • Nectar Lifesciences
  • Everest Organics

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Haleos Labs Ltd.
  • Nectar Lifesciences
  • Everest Organics

Cash Flow

  • Haleos Labs Ltd.
  • Nectar Lifesciences
  • Everest Organics

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Haleos Labs Ltd.
  • Nectar Lifesciences
  • Everest Organics

Quarterly Results

  • Haleos Labs Ltd.
  • Nectar Lifesciences
  • Everest Organics

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Haleos Labs Ltd. Financials

Balance sheet of Haleos Labs is moderately strong, But short term working capital might become an issue for this company.

The net debt of Haleos Labs is decreasing.
Latest net debt of Haleos Labs is ₹81.08 Crs as of Mar-25.
This is less than Mar-24 when it was ₹94.79 Crs.

The profit is oscillating.
The profit of Haleos Labs is ₹16.02 Crs for TTM, ₹20.11 Crs for Mar 2025 and ₹9.09 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Haleos Labs latest dividend payout ratio is 2.26% and 3yr average dividend payout ratio is 3.73%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech